Advertisement

The Latest

Danish drugmaker Novo Nordisk has agreed to pay the United States and several states more than $1.7 million to resolve allegations that it caused false claims to be submitted to Medicare in connection with its diabetes drug, Novolin, according to…

Premier has added six ophthalmology product companies to its portfolio, a healthy showing that dispels concerns about a supplier exodus from GPOs following Medtronic's rejection of GPO contracts, according to a report by Mass Device.

For traumatic and osteoarthritis, biologic joint replacements could be the wave of the future for surgery centers, said Kevin Stone, MD, The Stone Clinic at the 9th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference in Chicago on June 10.

Advertisement